Inorganic Polyphosphate Affects Biofilm Assembly, Capsule Formation, and Virulence of Hypervirulent ST23 Klebsiella pneumoniae

Rojas, Diego.; Marcoleta, Andres E.; Galvez-Silva, Matias; Varas, Macarena A.; Diaz, Mauricio; Hernandez, Mauricio; Vargas, Cristian; Nourdin-Galindo, Guillermo; Koch, Elard; Saldivia, Pablo; Vielma, Jorge; Gan, Yunn-Hwen; Chen, Yahua; Guiliani, Nicolas; Chavez, Francisco P.

Abstract

The emergence of hypervirulent Klebsiella pneumoniae (hvKP) strains poses a significant threat to public health due to high mortality rates and propensity to cause severe community-acquired infections in healthy individuals. The ability to form biofilms and produce a protective capsule contributes to its enhanced virulence and is a significant challenge to effective antibiotic treatment. Polyphosphate kinase 1 (PPK1) is an enzyme responsible for inorganic polyphosphate synthesis and plays a vital role in regulating various physiological processes in bacteria. In this study, we investigated the impact of polyP metabolism on the biofilm and capsule formation and virulence traits in hvKP using Dictyostelium discoideum amoeba as a model host. We found that the PPK1 null mutant was impaired in biofilm and capsule formation and showed attenuated virulence in D. discoideum compared to the wild-type strain. We performed a proteomic analysis to gain further insights into the underlying molecular mechanism. The results revealed that the PPK1 mutant had a differential expression of proteins involved in capsule synthesis (Wzi-Ugd), biofilm formation (MrkC-D-H), synthesis of the colibactin genotoxin precursor (ClbB), as well as proteins associated with the synthesis and modification of lipid A (ArnB-LpxC-PagP). These proteomic findings corroborate the phenotypic observations and indicate that the PPK1 mutation is associated with impaired biofilm and capsule formation and attenuated virulence in hvKP. Overall, our study highlights the importance of polyP synthesis in regulating extracellular biomolecules and virulence in K. pneumoniae and provides insights into potential therapeutic targets for treating K. pneumoniae infections.

Más información

Título según WOS: ID WOS:001161377600001 Not found in local WOS DB
Título de la Revista: ACS INFECTIOUS DISEASES
Volumen: 10
Número: 2
Editorial: AMER CHEMICAL SOC
Fecha de publicación: 2024
Página de inicio: 606
Página final: 623
DOI:

10.1021/acsinfecdis.3c00509

Notas: ISI